(JHMM) John Hancock Multifactor - Ratings and Ratios
Exchange: NYSE ARCA • Country: USA • Currency: USD • Type: Etf • ISIN: US47804J2069 • Mid-Cap Blend
JHMM: Index, Mid-Cap, ETF, NYSE, Equity
The John Hancock Multifactor Mid Cap ETF (NYSE ARCA: JHMM) is designed to track the performance of a specific index that focuses on U.S. mid-capitalization companies. The fund typically allocates at least 80% of its net assets to securities included in its underlying index. This index is constructed to represent a targeted segment of the U.S. equity market, specifically companies ranked between the 200th and 951st largest by market capitalization during its periodic reconstitution. This approach aims to capture the performance of mid-sized companies that may exhibit growth potential and relatively stable earnings compared to smaller or larger counterparts.
The ETF employs a multifactor investment strategy, incorporating various drivers such as value, momentum, and quality to select securities. This methodology seeks to enhance returns and manage risk by diversifying across multiple factors. The funds mid-cap focus positions it to capitalize on companies that may be more established than small-caps but still have room for growth, potentially offering a balance between stability and expansion opportunities.
From a technical perspective, JHMM is currently trading at $55.68, slightly below its 20-day simple moving average (SMA) of $54.35 but significantly below its 200-day SMA of $59.09. This indicates a recent downtrend in price momentum. The 50-day SMA of $57.09 further suggests intermediate-term weakness. The average true range (ATR) of 1.67 reflects moderate volatility, which could imply manageable risk for traders seeking precision in their entries and exits.
Fundamentally, the ETF has a substantial asset base of $3.618 billion, underscoring its liquidity and investor confidence. This scale often allows for tighter bid-ask spreads and lower trading costs, making it accessible for both retail and institutional investors. The funds mid-cap blend category positions it as a core holding for portfolios seeking exposure to this market segment.
3-Month Forecast: Based on the convergence of technical and fundamental data, JHMM is expected to experience sideways to slightly bearish price action in the near term. The ETFs current price is below its 200-day SMA, signaling bearish momentum, while the narrowing gap between the 20-day and 50-day SMAs suggests potential consolidation. However, the moderate ATR and strong AUM provide a foundation for stability. If the price fails to break above the 50-day SMA, it may test lower support levels. Conversely, a breakout above $57.09 could signal a recovery, driven by improving market sentiment or strengthening fundamentals in the mid-cap sector.Additional Sources for JHMM ETF
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
JHMM ETF Overview
Market Cap in USD | 3,754m |
Category | Mid-Cap Blend |
TER | 0.42% |
IPO / Inception | 2015-09-28 |
JHMM ETF Ratings
Growth Rating | 61.7 |
Fundamental | - |
Dividend Rating | 47.7 |
Rel. Strength | -5.09 |
Analysts | - |
Fair Price Momentum | 52.90 USD |
Fair Price DCF | - |
JHMM Dividends
Dividend Yield 12m | 1.05% |
Yield on Cost 5y | 1.95% |
Annual Growth 5y | 5.26% |
Payout Consistency | 95.9% |
JHMM Growth Ratios
Growth Correlation 3m | -77.2% |
Growth Correlation 12m | 34.5% |
Growth Correlation 5y | 71.2% |
CAGR 5y | 13.23% |
CAGR/Max DD 5y | 0.55 |
Sharpe Ratio 12m | 0.53 |
Alpha | -5.02 |
Beta | 0.906 |
Volatility | 26.20% |
Current Volume | 139.7k |
Average Volume 20d | 176.4k |
As of May 09, 2025, the stock is trading at USD 57.80 with a total of 139,701 shares traded.
Over the past week, the price has changed by +2.92%, over one month by +14.86%, over three months by -6.95% and over the past year by +5.02%.
Yes. Based on ValueRay Analyses, John Hancock Multifactor (NYSE ARCA:JHMM) is currently (May 2025) a good stock to buy. It has a ValueRay Growth Rating of 61.67 and therefor a clear technical positive rating according to historical growth.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of JHMM as of May 2025 is 52.90. This means that JHMM is currently overvalued and has a potential downside of -8.48%.
John Hancock Multifactor has no consensus analysts rating.
According to ValueRays Forecast Model, JHMM John Hancock Multifactor will be worth about 59.8 in May 2026. The stock is currently trading at 57.80. This means that the stock has a potential upside of +3.37%.
Issuer | Forecast | Upside |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 59.8 | 3.4% |